TL
TriSalus Life Sciences Inc.
🇺🇸XNAS.TLSIUnited StatesHealthcare
$3.27USDdown -0.19 (-5.49%)ClosedEnd of day10:42 PM
Price$3.27-0.19 (-5.49%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US89680M1018
- CUSIP
- 054603105
Company
- Employees
- 102
- Headquarters
- Westminster, United States
- Website
- https://trisaluslifesci.com
- CEO
- Ms. Mary T. Szela B.S.N., M.B.A.
Market
- Shares outstanding
- 61.6M
- Market cap
- $200.83M
Highlights
- Market cap
- $200.83M
- EPS LTM
- -$0.48
- P/E LTM
- -6.76calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $45.08M+25.25%up year on year
- Net income
- -$28.21M+9.49%up year on year
- Gross margin
- 85.79%+1.32%up year on year
- Free cash flow
- -$29.9M-2.22%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.